Sir, Foveoschisis after vitrectomy for myopic macular hole with secondary retinal detachment Macular foveoschisis is a recently identified cause for visual loss in pathological myopia.
Comment
Tornambe 4 suggested that a macular hole can occur in the absence of vitreous traction; microtrauma to the fovea during posterior vitreous detachment results in foveal hydration, deroofed by centrifugal tangential traction of ILM. A similar mechanism could have operated in this postvitrectomy macular hole, which closed with a central defectFa common observation in myopic staphylomata with RD. 5 Its discontinuous edges were more vulnerable to fluid ingress due to weak adhesion to the degenerated retinal pigment epithelium, which would also result in poor pumping out of the intraretinal fluid. Indeed, minimal intraretinal fluid was noted postoperatively, which, however, resolved spontaneously. Because of the limitations of OCT imaging in a myopic staphyloma, we cannot rule the presence of a subtle epiretinal membrane producing the schisis. However, as both anteroposterior and tangential tractions were surgically eliminated, this possibility appears unlikely. For the same reason, we believe that foveoschisis would probably not progress to reopening of the macular hole over further follow-up. 6 This unusual developmentFnever reported previously as a postsurgical eventFendorses the recent view that vitreous traction may not be critically important in pathogenesis of myopic foveoschisis.
2,3 Further implications and actual incidence of this seemingly rare event can only be assessed by large scale interventional case studies with long-term OCT-documented follow-ups.
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Retina-Vitreous Service, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu, India E-mail: daksh66@gmail.com Bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor, has been given as an intravitreal injection for choroidal neovascularization (CNV) secondary to age-related macular degeneration, 1 myopia, 2 and angioid streaks 3 with promising functional results. Here, we present a case of subfoveal CNV secondary to traumatic choroidal rupture, which regressed with intravitreal bevacizumab. We are unaware of such a report in world literature.
Case report
A 25-year-old woman presented with diminution of vision in her right eye for 1-month duration. The patient had sustained a blunt injury in the right eye with a ball 4 months back.
The best-corrected visual acuity (BCVA) was 20/200 OD and 20/20 OS. Anterior segment examination was normal bilaterally. The intraocular pressures were 10 mmHg bilaterally. Ophthalmoscopic examination of the right eye revealed a curvilinear choroidal rupture just temporal to the fovea with a small, orange-coloured subfoveal lesion and associated subretinal haemorrhage (Figure 1 ). Left eye fundus was normal.
Fluorescein angiography (FA) showed transmission hyperfluorescence corresponding to the choroidal rupture and an associated subfoveal hyperfluorescent lesion with late leakage of dye in the right eye. Optical coherence tomography (OCT) revealed the presence of a subfoveal CNV with intraretinal oedema in the right eye
